10th annual US India BioPharma Summit Boston June 2

Nature Publishing Group continues its long standing tradition of providing the means for product manufacturers, service providers, publishers and other corporations to reach members of the scientific community who have opted-in to receive such messages. Nature Publishing Group does not endorse any of the products or services advertised here. To forward this email to a friend, please click here.

U S A I C   USA-India Chamber of Commerce presents its 10th annual BioPharma & Healthcare Summit Date: Thursday, June 2, 2016 Time: 9-00 AM to 7-30 PM Location: Marriott Cambridge, Massachusetts, USA Register online at http://www.usaindiachamber.org/ EMCEE: Dr. Andrew Plump, Chief Medical & Scientific Officer and Board Member, Takeda Networking Tea Breaks, Hosted Lunch, Cocktails & High Power Networking Reception Registration Closes May 25 subject to availability Advisory Board Dr. M.K. Bhan, former Secretary to the Government of India, Department of Biotechnology Hari Bhartia, Co-Chairman, Jubilant Life Sciences Dr. Barry Bloom, Professor and past Dean, Harvard School of Public Health D.S. Brar, Chairman, GVK Biosciences Dr. William Chin, Executive Vice President- Scientific and Regulatory Affairs, PhRMA Dr. Mikael Dolsten, President - Worldwide R&D, Pfizer Dr. Jeffrey Flier, Dean, Harvard Medical School Dr. Ansbert Gadicke, Founder & Managing Partner, MPM Capital Dr. Laurie Glimcher, Dean & Provost for Medical Affairs, Cornell University Dr. Nirmal Ganguly, former Director General, Indian Council of Medical Research Dr. Rakesh Jain, Director, E.L. Steele Laboratories, MGH/Harvard Medical School Dr. Bahija Jallal, Executive Vice President, MedImmune Dr. Robert King, Senior Partner, Goldman Sachs Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School Dr. Martin Mackay, Exe. Vice President, Global Head of R&D, Alexion Pharmaceuticals Dr. Peter Mueller, President of R&D and Chief Scientific Officer, Pronutria BioSciences Dr. John Orloff, Global Head of R&D, Baxalta Dr. David Nicholson, Head of Brand R&D, Actavis Dr. Andrew Plump, Chief Medical and Scientific Officer, Takeda, Pharmaceuticals Prof. K. VijayRaghavan, Secretary to the Government of India, Department of Biotechnology Prof. K. Srinath Reddy, President, Public Health Foundation of India Dr. Michael Rosenblatt, Executive Vice President and CMO, Merck & Co. Dr. Al Sandrock, Executive Vice President and CMO, Biogen Kiran Mazumdar-Shaw, Chairman, Biocon Dr. Paul Stoffels, Chief Scientific Officer, Johnson & Johnson K.V. Subramaniam, President, Reliance Life Sciences Dr. Naresh Trehan, Chairman, Medanta- The Medicity Dr. Elias Zerhouni, President Global R&D, Sanofi Panel Discussions & Keynotes Covering Drug Discovery and Collaborative Research Role of Genetics in:    Oncology    Neurodegenerative Diseases    Cardiovascular & Metabolic Diseases Prime Time for ACGTs The new final frontier- CRISPR Industry-Academic Research Partnership Clinical Trials- India update Licensing, IP & Regulatory Issues Funding Innovation, Cross Border Investments and M&A trends Emerging Markets- Opportunities & Strategies Breakfast Strategy sessions (by invitation only) Role of Genetics- Co-Chairs: Dr. Philip Larsen, Global Head of Diabetes R&D, Sanofi; Dr. John Reynders, Vice President, Alexion: Dr. Vijay Chandru, Chairman, Strand Lifesciences External Research Strategies- Co-Chairs: Dr. Sridaran Natesan, Vice President, Sanofi USA; Dr. Meeta Chatterjee, Head of Business Strategy and Operations, MRL; Dr. Sandeep Gupta, CEO, Asana BioSciences Highlights Annual high profile summit of established and emerging BioPharma, Medical Devices, Venture Capitalists, Policy Makers and Academia from the US, Europe and India Annual R&D spend of just the Advisory Board members in excess of $25 billion THE Bio Pharma event in the world focused on BioPharma, Medical Devices and Healthcare 5+ Networking Opportunities with Industry Leaders, Investors, Academicians and Policy Makers Learn: Discuss, debate and understand new models in R&D, partnering and commercial models - DIRECTLY from major implementers Share: Maximize collaborations with the world’s leading innovators, investors and executives in the healthcare industry Network: Meet the top global industry thought leaders, investors, academicians and policy makers at one location Benefit: Utilize and implement key takeaways and insights from the meeting in your own business and return to share your feedback to guide others Annual summit provides continuity and results by bringing key stakeholders together A forum open only to senior executives Register online at http://www.usaindiachamber.org/ Limited Seats. Registration rates will go up soon. We encourage you to share the Summit details with your industry colleagues. *Program and speakers subject to change USA-India Chamber of Commerce Tel: 781 586-1212 info@usaindiachamber.org Twitter: @USAIC   As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive third-party emails. If you no longer wish to receive third-party emails from Nature Publishing Group please unsubscribe here or update your online account. For further information on technical assistance | print subscriptions | other enquiries. Customer Service Dept. Nature Publishing Group One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group | Principal offices: London | New York | Tokyo. Worldwide offices: Basingstoke | Boston | Buenos Aires | Delhi | Madrid | Melbourne | Mexico City | Munich | Paris | San Francisco | Sao Paulo| Seoul | Shanghai | Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.